DAVID P. PERRY - 08 Jun 2021 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
Director
Signature
/s/ Daniel S. Char, Attorney-in-Fact for David P. Perry
Issuer symbol
EVLO on OTC
Transactions as of
08 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 16:06:08 UTC
Previous filing
01 Nov 2021
Next filing
01 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +15,690 $0.000000 15,690 08 Jun 2021 Common Stock 15,690 $14.60 Direct F1
transaction EVLO Stock Option (Right to Buy) Award $0 +1,810 $0.000000 1,810 09 Jun 2021 Common Stock 1,810 $14.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 8, 2022 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.